Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Purchase Molecular Probes for $325M

NEW YORK, July 2 - Carlsbad, Calif.-based Invitrogen today announced the purchase of privately-held Molecular Probes of Eugene, Ore., in a $325 million cash transaction expected to close in the third quarter.


The acquisition brings together Invitrogen, a genomic research reagents, software and service provider with 28-year-old Molecular Probes, a provider of fluorescence-based technologies. With a market capitalization of nearly $2 billion, Invitrogen reported revenues of $181 million for the third quarter ending March 31.


Molecular Probes, founded in 1975, had revenues of $56 million in 2002, Invitrogen said.


With the sale, Invitrogen is aiming to position itself in the drug discovery and development sector, Greg Lucier, the company's CEO said in a statement.


The Scan

Could Mix It Up

The US Food and Drug Administration is considering a plan that would allow for the mixing-and-matching of SARS-CoV-2 vaccines and boosters, the New York Times says.

Closest to the Dog

New Scientist reports that extinct Japanese wolf appears to be the closest known wild relative of dogs.

Offer to Come Back

The Knoxville News Sentinel reports that the University of Tennessee is offering Anming Hu, a professor who was acquitted of charges that he hid ties to China, his position back.

PNAS Papers on Myeloid Differentiation MicroRNAs, Urinary Exosomes, Maize Domestication

In PNAS this week: role of microRNAs in myeloid differentiation, exosomes in urine, and more.